✉news HealthMedicine first seen 13 h ago, last 5 h ago, peak #11
New multi-omics cohort launched for sepsis precision medicine
Original: CMAISE: Establishing the longitudinal multi-omics cohort for sepsis precision medicine
Researchers have announced CMAISE, a longitudinal multi-omics cohort study aimed at advancing precision medicine for sepsis, a life-threatening condition with limited treatment options. By tracking patients over time and integrating genomic, proteomic and other molecular data, the project seeks to identify biomarkers that could enable tailored therapies. The announcement has drawn attention from the medical research community interested in sepsis diagnostics.
Why now: Sepsis remains a major unmet medical need, and a large-scale multi-omics cohort is seen as a significant step toward personalised treatment.
Rank over time, top of the chart is #1. 7 snapshots from 13 h ago to 5 h ago.
Evidence
- CMAISE: Establishing the longitudinal multi-omics cohort for sepsis precision medicine · eurekalert.org
API: https://socialmediatrends-api.osmike.com/v1/trends/765881